Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual nature walks could soothe heart attack patients in intensive care

NCT ID NCT07696390

Symptom relief Sponsor: Yuzuncu Yil University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests whether watching nature videos through virtual reality glasses can lower anxiety and improve vital signs like heart rate and blood pressure in people recovering from a heart attack in the intensive care unit. Half of the 50 participants will use VR glasses for a short session, while the other half will receive standard care. Researchers will measure anxiety levels and vital signs before and after the session to see if VR offers a calming benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality glasses showing nature videos
What this could lead to
If effective, virtual reality could become a simple, drug-free way to ease anxiety and stabilize vital signs in heart attack patients during intensive care.
What could go wrong
This is a small, early-stage study with only 50 participants. The effect may be small or not last, and not all patients may find VR helpful or comfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The patient is in intensive care. 2. The patient has been diagnosed with myocardial infarction. 3. The patient is between 18 and 70 years old. 4. The patient is conscious. 5. The patient is oriented and cooperative. 6. The patient volunteers to participate in the study. 7. The patient is open to communication. 8. The patient agrees to participate in the study. 9. The patient has no mental, visual, auditory, or speech impairment. 10. The patient has undergone stent placement. 11. The patient has STEMI. Exclusion Criteria: 1. The patient has a psychiatric disorder. 2. The patient has any communication impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocardial infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • SBU Van Training and Research Hospital

    RECRUITING

    Van, 65, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.